1. Mendelian
  2. Experts
  3. ACUTE PROMYELOCYTIC LEUKEMIA Experts by country

ACUTE PROMYELOCYTIC LEUKEMIA Experts

We have collected the completed list of expert related to ACUTE PROMYELOCYTIC LEUKEMIA using public data available on different databases.

ACUTE PROMYELOCYTIC LEUKEMIA Experts map



If you find this map or researchers for ACUTE PROMYELOCYTIC LEUKEMIA useful, maybe you will be also interested in other rare diseases proffesionals like our huntington disease expert list ,or our leukemia, acute lymphoblastic; all expert list

ACUTE PROMYELOCYTIC LEUKEMIA Experts list

Pr Peter A VANDENBERGHE

 LEUVEN. BELGIUM

  Responsible for diagnostic tests - Investigator of research project

  • Research area/topic:
    The role of RAS- and RHO-GTPases, their regulators and mediators in the pathogenesis of myeloid malignancies.
  • Department of Human Genetics, University Hospitals Leuven - Gasthuisberg
  • peter.van*********@***euven.be
Complete Info

Pr Uwe PLATZBECKER

 DRESDEN. GERMANY

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project

  • Research area/topic:
    NAPOLEON Registry of the German AML Intergroup - National acute promyelocytic leukemia observational study
  • Universitätsklinikum Carl Gustav Carus an der TU Dresden
    Universitätsklinikum Carl Gustav Carus an der TU Dresden
  • uwe.pla********@***klinikum_dresden.de
Complete Info

Dr Susanne SAUßELE

 MANNHEIM. GERMANY

  Coordinator of expert centre - Clinical expert - Principal investigator of clinical trial - Investigator of research project - Coordinator of research network

  • Research area/topic:
    Competence Network 'acute and chronic leukemias'
  • III. Medizinische Universitäts-Klinik, Universitätsklinikum Mannheim
    Universitätsmedizin Mannheim
  • susanne.********@***ma.uni_heidelberg.de
Complete Info

Pr Jochen GREINER

 STUTTGART. GERMANY

  Investigator of research project

  • Research area/topic:
    AMLSG 18-12: Maintenance therapy with Histamine Dihydrochloride and Interleukin-2 in adult AML patients with measurable minimal residual disease - a Non-interventional Study
  • Diakonie-Klinikum Stuttgart
  • gre****@***k_stuttgart.de
Complete Info

Other experts list that you may find interesting:

All the contact information provided is based on public data available in orpha.net.